Pfizer (PFE) Stock: Buy, Sell, or Hold?

PFE - Pfizer Inc.

PHARMACEUTICAL PREPARATIONS
$28.12
-0.40 (-1.40%) â–ŧ
5d: -1.02%
30d: -1.51%
90d: +15.63%
WAIT
LOW Confidence
Protect Your PFE Gains
Analysis Updated: Oct 1, 2026 12:00 AM ET
Earnings: Nov 03, 2026

Get Alerted When PFE Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
â„šī¸ NEUTRAL: PFE is fairly priced but lacks strong directional signals. At 2.0% expected growth, valuation appears fair. Wait for clearer setup or better entry on dips.
See Forward Earnings Fair Value & Price Prediction →

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$27.26
Based on 0.7% avg growth
INTRINSIC VALUE TODAY
$16.93
Trading above historical range

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 9.1x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: PFE is currently trading at $28.12, which is considered fair relative to its 30-day fair value range of $27.71 to $28.58. The stock's valuation (Forward PE: 9.7) is in line with its historical norms (9.1). At these levels, the market is pricing in 2.0% annual earnings growth.

Technical Outlook: Technically, PFE is in a strong uptrend. The price is currently testing key support at $27.34. A bounce from this level would confirm strength, while a break below could signal further downside.

Market Sentiment: PFE scores 28/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position FAIR
Historical Trading Range $27.71 - $28.58
Company Quality Score 45/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 48.6%

Protect Your Profits

Holding PFE? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

  • NEUTRAL: Price in fair range
  • BEARISH: Weak technical setup (28/100)
  • BULLISH: High volume confirmation
  • NEUTRAL: Near Wall St target ($28.88)
  • BULLISH: Expecting earnings turnaround to 2.0% growth with 2.6% revenue growth
  • WARNING: Composite score 45/100 in the bottom quintile — this cohort historically lags the market

Trading Range Analysis

30-Day Trading Range $27.71 - $28.58
Current vs Trading Range FAIR

Support & Resistance Levels

Support Level $27.34
Resistance Level $28.95
Current Trend Strong Uptrend
Technical data as of Oct 1, 2026

Fundamental Context

Forward P/E (Next Year Est.) 9.71
Wall Street Target $28.88 (+2.7%)
Revenue Growth (YoY) 2.6%
Earnings Growth (YoY) -10.1%
Profit Margin 6.8%
Valuation Premium vs History +2.0% premium
PE vs Historical 9.7 vs 9.1 FAIR
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): +2.0% (market-implied from PE analysis)
1-Year Target $28.68 (+2%)
2-Year Target $29.26 (+4%)
3-Year Target $29.84 (+6%)
3-Yr Target (if PE normalizes) (PE: 10→9) PE COMPRESSION $27.97 (-1%)
Earnings growth offset by PE compression
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 20.4, Growth: -2.6%) $54.56 (+94%)
Base: (SPY PE: 9.7, Growth: -2.6%) $25.96 (-8%)
Bear: (PE: 8.3, Growth: -2.6%) $22.07 (-22%)
📈 Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (38x PE), but valuation improves significantly next year (10x PE) as earnings recover.
Trailing PE: 37.53 | Current EPS (TTM): $0.76
Bull Case $62.74 (+123%)
Analyst growth 100.0%, PE expands to 41.3
Base Case $57.04 (+103%)
Market implied 100.0%, PE stable at 37.5
Bear Case $19.39 (-31%)
Severe decline -20.0%, PE contracts to 31.9
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: October 02, 2026 8:31 AM ET
Data refreshes hourly during market hours. Next update: 9:31 AM
đŸ”Ĩ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for PFE.

Create Free Account

Already have an account? Log In

Featured in Portfolios

PFE is a key holding in these high-performance investment strategies.

Top Rated Drug Manufacturers - General Stocks

Top-rated stocks in Drug Manufacturers - General by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
LLY
Eli Lilly and Company
STRONG BUY
31 analysts
$1325 51 HOLD
GILD
Gilead Sciences Inc
BUY
30 analysts
$159 51 HOLD
ABBV
AbbVie Inc
BUY
28 analysts
$279 56 HOLD
MRK
Merck & Company Inc
BUY
26 analysts
$154 55 HOLD
AMGN
Amgen Inc
HOLD
32 analysts
$389 46 HOLD

Advanced PFE Option Strategies

Professional options setups generated by AI based on today's PFE price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for PFE

PFE Technical Chart PFE Price Prediction PFE Earnings Date PFE Investment Advisor PFE Fair Price Analyzer PFE Options Advisor PFE Options Chain PFE Options Analysis PFE Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals